Synaptogenix Has Received A Notice Of Allowance For Its U.S. Patent Application 17/665,033 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases"
Synaptogenix Has Received A Notice Of Allowance For Its U.S. Patent Application 17/665,033 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases"
Synaptogenix已收到批准其美國專利申請17/665,033的通知，該專利名爲 “用於治療神經退行性疾病的環丙烷化不飽和脂肪酸的滷代酯”
Synaptogenix Has Received A Notice Of Allowance For Its U.S. Patent Application 17/665,033 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases"
Synaptogenix已收到批准其美國專利申請17/665,033的通知，該專利名爲 “用於治療神經退行性疾病的環丙烷化不飽和脂肪酸的滷代酯”
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。